At age 40, Josie Rubio, a writer and editor, was dying of cancer and "unexpectedly single" after her boyfriend of 12 years "reconnected" with an old friend in London. In a New York Times opinion piece, Rubio shares what it's like to be "dating while dying."
Congress is entering the last week of its recess, but lawmakers already have a loaded agenda for when they return—and some of their biggest priorities deal with health care. Daily Briefing's Ashley Fuoco Antonelli has rounded up the three biggest priorities for the upcoming session.
Scientists at Weill Cornell Medicine are trying to use the gene-editing technology CRISPR to edit DNA within human sperm, but some experts are questioning whether the practice is ethical, Rob Stein writes for NPR's "Shots."
Sabrina Strong, a lawyer for Johnson & Johnson, said, "We have many strong grounds for appeal and we intend to pursue those vigorously." According to the Times, it is unclear whether the appellate courts would affirm Balkman's verdict.
When a doctor recommends a treatment, we usually assume "it's based on solid evidence," but research shows that the number of popular clinical treatments that have been proven beneficial is "less than you might think," Austin Frakt writes for the New York Times' "The Upshot."